AQR Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.74M	Buy	485,233 +16,793	+4%	+$268K	﹤0.01%	1557
2025 Q4	$7.61M	Sell	468,440 -140,561	-23%	-$2.29M	﹤0.01%	1339
2025 Q3	$9.11M	Buy	609,001 +176,598	+41%	+$2.15M	0.01%	1136
2025 Q2	$5.04M	Buy	432,403 +122,131	+39%	+$1.11M	﹤0.01%	1286
2025 Q1	$2.26M	Buy	310,272 +97,444	+46%	+$749K	﹤0.01%	1537
2024 Q4	$1.28M	Sell	212,828 -49,136	-19%	-$271K	﹤0.01%	1759
2024 Q3	$1.34M	Buy	261,964 +79,888	+44%	+$348K	﹤0.01%	1705
2024 Q2	$635K	Buy	182,076 +129,201	+244%	+$410K	﹤0.01%	1940
2024 Q1	$168K	Buy	52,875 +13,350	+34%	+$51.7K	﹤0.01%	2282
2023 Q4	$194K	Buy	39,525 +26,313	+199%	+$120K	﹤0.01%	2222
2023 Q3	$72K	Sell	13,212 -12,449	-49%	-$82.3K	﹤0.01%	2262
2023 Q2	$172K	Sell	25,661 -15,962	-38%	-$119K	﹤0.01%	2098
2023 Q1	$360K	Sell	41,623 -28,794	-41%	-$254K	﹤0.01%	1883
2022 Q4	$525K	Buy	70,417 +30,856	+78%	+$240K	﹤0.01%	1797
2022 Q3	$282K	Sell	39,561 -48,309	-55%	-$455K	﹤0.01%	1962
2022 Q2	$688K	Sell	87,870 -75,420	-46%	-$663K	﹤0.01%	1563
2022 Q1	$2.27M	Buy	+163,290	New	+$2.57M	﹤0.01%	1112
2021 Q2	–	Sell	-18,721	Closed	-$734K	–	2215
2021 Q1	$734K	Buy	+18,721	New	+$1.01M	﹤0.01%	1684